the natives are getting restless...., page-32

Hello Kranky,

what you have just done is regurgitate exactly what ECT had disclosed to it's shareholders in their ASX Ann. "Shareholder Update" Pg 3-dated 15.06.2012. "There has been considerable discussion about the use of equity....."

All you have done is lace the subject of dilution with your concerns as a non SH. There is no surprise to us SH's in what you have stated in your post. All you seem to be doing is raising alarm bells on a deal that has not been completed. There are also alot if "if's" in the points of concern you raise. It's as informative as telling SH's what the SP was on a certain day-we can all get that information from the ASX website.

There seems to be a trend being established by you. I was more than happy to collaborate and inform posters such as yourself, but to be honest I am growing tired of what I am reading recently. It's always a case of DYOR, and if interested become a SH.

These posts are continually going in circles on points to subject connected to deals that have not been completed yet. Being a Spec stock it will be risk vs reward.

If you think that ECT are interested in securing $4m to complete DFT 2&3 and provide working capital only, (effectively paperwork and patents) and this will be the end of the ECT story then I suggest you move on. For the rest of us, as SH's we see a different picture forming. This last part in IMHO.

Best of luck to all.